3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
6
Prostatic Neoplasms
4
Rectal Neoplasms
2
Melanoma
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Breast Neoplasms
2
Brain Neoplasms
2
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Ependymoma
1
Astrocytoma
1
Advanced Prostate Adenocarcinoma
1
Interventions
cediranib
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Prostate Adenocarcinoma
×
cediranib
×
Genitourinary
×
Clear all
NCT00502164
2011-01-21
AZD2171IL/0003
AstraZeneca
Phase 1
Completed
40 enrolled